Published in Clin Transplant on December 30, 2012
Selection tool alpha-fetoprotein for patients waiting for liver transplantation: How to easily manage a fractal algorithm. World J Hepatol (2015) 0.83
Liver masses: a clinical, radiologic, and pathologic perspective. Clin Gastroenterol Hepatol (2013) 0.81
Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome. ISRN Hepatol (2014) 0.75
Impact of locoregional therapy and alpha-fetoprotein on outcomes in transplantation for liver cancer: a UNOS Region 6 pooled analysis--conclusion about locoregional therapy. Clin Transplant (2013) 0.75
Liver transplantation for advanced hepatocellular carcinoma. Clin Mol Hepatol (2016) 0.75
Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma. World J Hepatol (2016) 0.75
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis (2013) 10.92
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis (2010) 10.03
A randomized placebo-controlled trial of methotrexate in psoriatic arthritis. Rheumatology (Oxford) (2012) 3.56
2003 report of the intestine transplant registry: a new era has dawned. Ann Surg (2005) 2.27
The diagnosis and prognosis of early arthritis: rationale for new prognostic criteria. Arthritis Rheum (2002) 2.15
Comparison of oligonucleotide ligation assay and consensus sequencing for detection of drug-resistant mutants of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and plasma. J Clin Microbiol (2004) 1.97
Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantation. Hepatology (2012) 1.82
Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis. J Rheumatol (2005) 1.81
Clinical factors predicting readmission after orthotopic liver transplantation. Liver Transpl (2012) 1.66
Rat cytomegalovirus-accelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33. Am J Transplant (2005) 1.63
Illness beliefs predict disability in rheumatoid arthritis. J Psychosom Res (2009) 1.62
HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis. Hepatology (2007) 1.60
Remission in early rheumatoid arthritis. J Rheumatol (2010) 1.55
Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis (2010) 1.54
Exfoliative rejection after intestinal transplantation in children. Pediatr Transplant (2003) 1.48
Chronic rejection of small bowel grafts: pediatric and adult study of risk factors and morphologic progression. Pediatr Dev Pathol (2003) 1.44
Cost-effectiveness of combination nonbiologic disease-modifying antirheumatic drug strategies in patients with early rheumatoid arthritis. J Rheumatol (2011) 1.40
Randomized, phase II study of the insulin-like growth factor-1 receptor inhibitor IMC-A12, with or without cetuximab, in patients with cetuximab- or panitumumab-refractory metastatic colorectal cancer. J Clin Oncol (2010) 1.38
Bleeding esophagogastric varices from extrahepatic portal hypertension: 40 years' experience with portal-systemic shunt. J Am Coll Surg (2002) 1.38
Prescribed exercise in people with fibromyalgia: parallel group randomised controlled trial. BMJ (2002) 1.37
Graft versus host disease in intestinal transplantation. Am J Transplant (2004) 1.35
Patent human infections with the whipworm, Trichuris trichiura, are not associated with alterations in the faecal microbiota. PLoS One (2013) 1.30
Human cytomegalovirus secretome contains factors that induce angiogenesis and wound healing. J Virol (2008) 1.23
Huntingtin associates with acidic phospholipids at the plasma membrane. J Biol Chem (2005) 1.22
Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am J Transplant (2003) 1.21
Fibromyalgic rheumatoid arthritis and disease assessment. Rheumatology (Oxford) (2010) 1.21
Co-morbidities in established rheumatoid arthritis. Best Pract Res Clin Rheumatol (2011) 1.19
Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants. J Virol (2003) 1.18
Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg (2002) 1.16
The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis. J Rheumatol (2005) 1.16
African American living-kidney donors should be screened for APOL1 risk alleles. Transplantation (2011) 1.15
High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch Surg (2003) 1.14
Donation after cardiac death: the University of Wisconsin experience. Ann Transplant (2004) 1.14
Acceleration of allograft failure by cytomegalovirus. Curr Opin Immunol (2007) 1.13
A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis. Rheumatology (Oxford) (2009) 1.13
Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma. Cancer Res (2002) 1.10
Cutaneous cryptococcosis in solid organ transplant recipients. Med Mycol (2010) 1.09
Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression. Am J Transplant (2005) 1.09
Models of influence in chronic liver disease. Liver Int (2009) 1.07
Setting goals, solving problems, and seeking social support: developing adolescents' abilities through a life skills program. Adolescence (2007) 1.07
Rat cytomegalovirus gene expression in cardiac allograft recipients is tissue specific and does not parallel the profiles detected in vitro. J Virol (2007) 1.05
Advancing the high throughput identification of liver fibrosis protein signatures using multiplexed ion mobility spectrometry. Mol Cell Proteomics (2014) 1.04
The impact of disease activity, pain, disability and treatments on fatigue in established rheumatoid arthritis. Clin Rheumatol (2011) 1.03
Strain-specific T-cell suppression and protective immunity in patients with chronic hepatitis C virus infection. J Virol (2005) 1.03
CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma. Cancer Res (2003) 1.03
Quality of life and the outcome of established rheumatoid arthritis. Best Pract Res Clin Rheumatol (2011) 1.00
The role of cytomegalovirus in angiogenesis. Virus Res (2010) 0.99
Intestinal transplantation: a coming of age. Adv Surg (2002) 0.98
Cytomegalovirus microRNA expression is tissue specific and is associated with persistence. J Virol (2010) 0.95
Hepatitis C infection increases the risk of new-onset diabetes after transplantation in liver allograft recipients. Am J Surg (2005) 0.95
Pediatric liver transplantation. A single center experience spanning 20 years. Transplantation (2002) 0.95
Unrecognized pretransplant and donor‐derived cryptococcal disease in organ transplant recipients. Clin Infect Dis (2010) 0.94
Development and validation of a patient-based disease activity score in rheumatoid arthritis that can be used in clinical trials and routine practice. Arthritis Rheum (2008) 0.93
Epstein-Barr virus (EBV) related acute liver failure: a case series from the US Acute Liver Failure Study Group. Dig Dis Sci (2014) 0.93
Is shared care with annual hospital review better value for money than predominantly hospital-based care in patients with established stable rheumatoid arthritis? Ann Rheum Dis (2006) 0.93
Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry. Liver Transpl (2014) 0.91
The CHOICE survey: high rates of persistent and uncontrolled asthma in the United States. Ann Allergy Asthma Immunol (2012) 0.91
Patients' views about treatment with combination therapy for rheumatoid arthritis: a comparative qualitative study. BMC Musculoskelet Disord (2012) 0.91
Risk of esophageal variceal bleeding based on endoscopic ultrasound evaluation of the sum of esophageal variceal cross-sectional surface area. Am J Gastroenterol (2003) 0.90
Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis. Curr Opin Rheumatol (2008) 0.90
Homocysteine and arterial disease. Experimental mechanisms. Vascul Pharmacol (2002) 0.90
The experience of a regional pediatric intestinal failure program: Successful outcomes from intestinal rehabilitation. Am J Surg (2010) 0.89
Remission in early rheumatoid arthritis: predicting treatment response. J Rheumatol (2012) 0.89
Presence of tear lipocalin and other major proteins in lacrimal fluid of rabbits. Comp Biochem Physiol B Biochem Mol Biol (2004) 0.89
Pharmacokinetics of sirolimus and tacrolimus in pediatric transplant patients. Am J Transplant (2004) 0.89
PD-L1/PD-1 signal deficiency promotes allogeneic immune responses and accelerates heart allograft rejection. Transplantation (2008) 0.88
Kava-induced fulminant hepatic failure. J Am Acad Child Adolesc Psychiatry (2002) 0.87
Cytomegalovirus CC chemokine promotes immune cell migration. J Virol (2012) 0.87
Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial. Arthritis Rheum (2007) 0.87
Can we discontinue synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis? Clin Exp Rheumatol (2013) 0.86
Pain thresholds in rheumatoid arthritis: the effect of tender point counts and disease duration. J Rheumatol (2011) 0.86
Current limitations in the management of cardiovascular risk in rheumatoid arthritis. Clin Exp Rheumatol (2012) 0.86
Results of a phase II study of weekly paclitaxel plus carboplatin in patients with extensive small-cell lung cancer with Eastern Cooperative Oncology Group Performance Status of 2, or age > or = 70 years. J Clin Oncol (2004) 0.86
Current perspectives on tocilizumab for the treatment of rheumatoid arthritis: a review. Patient Prefer Adherence (2013) 0.86
Surgical treatment of intrahepatic cholangiocarcinoma: outcomes and predictive factors. HPB (Oxford) (2010) 0.84
Crystallization and preliminary X-ray analysis of recombinant human acid beta-glucocerebrosidase, a treatment for Gaucher's disease. Acta Crystallogr D Biol Crystallogr (2003) 0.84
Non-steroidal anti-inflammatory drugs and cardiac failure: meta-analyses of observational studies and randomised controlled trials. Eur J Heart Fail (2008) 0.84
Phase I adjuvant trial of sorafenib in patients with hepatocellular carcinoma after orthotopic liver transplantation. Anticancer Res (2013) 0.84
Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus. Transplantation (2002) 0.84
Perceived barriers to integrated care in rheumatoid arthritis: views of recipients and providers of care in an inner-city setting. BMC Musculoskelet Disord (2011) 0.84
New tumour necrosis factor inhibitors for rheumatoid arthritis: are there benefits from extending choice? Ann Rheum Dis (2009) 0.84
Liver transplantation in children with cystic fibrosis: a long-term longitudinal review of a single center's experience. J Pediatr Surg (2003) 0.84
Mouse cytomegalovirus M33 is necessary and sufficient in virus-induced vascular smooth muscle cell migration. J Virol (2005) 0.83
Drug therapy of inflammatory arthritis. Clin Med (2012) 0.83
Outcomes of simultaneous liver and kidney transplantation in relation to a high level of preformed donor-specific antibodies. Transplantation (2013) 0.83
Child-Turcotte score versus MELD for prognosis in a randomized controlled trial of emergency treatment of bleeding esophageal varices in cirrhosis. J Surg Res (2012) 0.83
Liver transplant recipients weaned off immunosuppression lack circulating donor-specific antibodies. Hum Immunol (2009) 0.83
Breath ammonia testing for diagnosis of hepatic encephalopathy. Dig Dis Sci (2005) 0.83
Comparative quality of life in patients with depression and rheumatoid arthritis. Int Rev Psychiatry (2011) 0.82
Helminth infection is associated with decreased basophil responsiveness in human beings. J Allergy Clin Immunol (2012) 0.82
ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial. Arthritis Res Ther (2014) 0.82
Survivin expression in juvenile-onset recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol (2002) 0.82
Bone resorption and "relative" immobilization hypercalcemia with prolonged continuous renal replacement therapy and citrate anticoagulation. Am J Kidney Dis (2004) 0.82
Comparative analysis of outcome following liver transplantation in US veterans. Am J Transplant (2004) 0.81
Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis. Am J Surg (2008) 0.81
Ultrashort bowel syndrome in children. J Pediatr Gastroenterol Nutr (2013) 0.81
Rat cytomegalovirus infection depletes MHC II in bone marrow derived dendritic cells. Virology (2009) 0.81